Abstract Tuberculosis (TB) remains a major global public health challenge, with treatment complicated by drug resistance, adverse effects, and suboptimal host immune responses. Whilst conventional anti-TB drugs are effective bactericidally, their immunomodulatory effects may, in certain contexts, contribute to immune imbalance and affect treatment outcomes.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Shihao
Contact Shihao, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack